[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
About Journal::
Editorial Board::
Articles Archive::
Indexing Databases::
To Authors::
To Reviewers::
Submit Your Article::
Policies and Publication Ethics::
Archiving Policy::
Site Facilities::
Contact Us::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 7, Issue 2 (3-2020) ::
2020, 7(2): 58-68 Back to browse issues page
Upregulation of SLC11A2 in gastric cancer patients with Helicobacter pylori infection
Hanieh Moallem Bandani , Fardin Ali Malayeri , Reza Haji Hosseini , Amirnader Emami Razavi
Department of Clinical Biochemistry, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran , falimalayeri@gmail.com
Abstract:   (1569 Views)
Introduction: H. pylori infection has a strong association with prevalence of iron deficiency and gastric cancer (GC). Cancer cells reprogram the iron metabolism in order to provide required iron. H. pylori is also need iron for its own growth and reproduction. SLC11A2 encodes a member of the solute carrier family 11 protein family which involved in transportation of divalent metals and iron absorption. We evaluated the relative expression of SLC11A2 in patients with GC and its relation to H. pylori infection and pathological characteristics of tumor.
Materials and methods: Forty-five patients with GC were involved in this research of whom 24 patients have been infected with H. pylori. Relative expression of SLC11A2 gene was estimated by quantitative real-time PCR. The relationship of SLC11A2 expression change with Pathological characteristics such as size and grade of tumor cells, lympho-vascular and perineural invasion and clinical stage of disease were evaluated in both infected and uninfected patients.
Results: SLC11A2 relative expression was significantly higher (P =0.026) in GC patients infected with H. pylori (11.33 ± 5.22) in comparison to those without infection (2.56 ± 0.65). Although it was not statistically significant, the expression of SLC11A2 in all participants was higher at higher stages (III &IV) of disease (9.84 ± 4.35) in comparison to those with lower stages (2.54 ± 0.75). However, among the patients infected with H. pylori, SLC11A2 expression was significantly (P= 0.027) upregulated in the higher stages of disease (16 ± 7.6) compare to the lower stages (1.8 ± 1.06).
Conclusion: SLC11A2 is probably a target gene for H. pylori in order to supply its need to iron. The relative expression changes of SLC11A2 in GC patients were associated with the infection of H. pylori, and pattern of its association with the prognosis of the disease changes in the presence and absence of infection with H. pylori.
Keywords: SLC11A2, Gastric cancer, H. pylori
Full-Text [PDF 300 kb]   (576 Downloads)    
Type of Study: Research | Subject: Cellular and molecular biology
Received: 2019/12/4 | Accepted: 2020/02/10 | Published: 2020/03/1
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moallem Bandani H, Ali Malayeri F, Haji Hosseini R, Emami Razavi A. Upregulation of SLC11A2 in gastric cancer patients with Helicobacter pylori infection. Journal of Basic Research in Medical Sciences 2020; 7 (2) :58-68
URL: http://jbrms.medilam.ac.ir/article-1-451-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 2 (3-2020) Back to browse issues page
مجله ی تحقیقات پایه در علوم پزشکی Journal of Basic Research in Medical Sciences
Persian site map - English site map - Created in 0.17 seconds with 41 queries by YEKTAWEB 4646